7:03AM Biosite and Eli Lilly to collaborate on clinical trial (BSTE) 50.21 : Co and Eli Lilly (LLY) announce an agreement to collaborate in connection with a clinical trial employing a tailored therapy strategy for Lilly's severe sepsis drug, Xigris. The trial will investigate the use of a multipurpose biomarker, Protein C, to be used in connection with the administration of Xigris.
Change is the only constant